Rare
lephants
Screener
Toggle theme
Biomerica, Inc.
BMRA
·
Healthcare, Drug Manufacturers - General, United States
Analysis
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
Cash Flow History
Net Cash Flow Breakdown
Net Cash Flow
Cash Flow
›
Net Cash Flow Breakdown
Net Cash Flow Breakdown
Chart
Table
FY2013
FY2012
FY2011
Total Cash from Operations:
$1.7M
Line Item
Value
% of Total
Capital Expenditures
$257.1K
15.6%
Other
$3.0K
0.2%
Net Cash Flow
$1.4M
84.3%
Download CSV
